Bhargav Earla

ORCID: 0009-0000-4658-1945

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Upregulation of Somatostatin Receptor Type 2 in a Receptor-Deficient In Vivo Pancreatic Neuroendocrine Tumor Model Improves Tumor Response to Targeted 177 Lu-DOTATATE”.

Upregulation of Somatostatin Receptor Type 2 in a Receptor-Deficient In Vivo Pancreatic Neuroendocrine Tumor Model Improves Tumor Response to Targeted 177 Lu-DOTATATE

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.25.489401

N/A

0.208DataRank · unranked

3 citations

Bhargav Earla, Kwamena E. Baidoo, Martha A. Zeiger, James P. Madigan, Freddy E. Escorcia +2 more

Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-22-0798

N/A

0DataRank · unranked

13 citations

Bhargav Earla, Kwamena E. Baidoo, Martha A. Zeiger, James P. Madigan, Freddy E. Escorcia +2 more